ArticleResearch and practice in thrombosis and haemostasis2026
Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Clinical characteristics and outcomes of patients with cancer with symptomatic vs incidental venous thromboembolism (VTE) remain poorly described. Methods: In this Results: Of 284 patients, 163 (57%) had incidentally detected VTE. Compared with symptomatic patients, incidental patients had lower body mass index, more metastatic disease (79% vs 57%), and more pulmonary embolism or abdominal vein thrombosis. Deep vein thrombosis of the leg was more frequent in the symptomatic group (45.4% vs 7.4%, Conclusion: The characteristics and outcomes in patients with incidental VTE differed from those with symptomatic VTE. While VTE recurrence was similar between the two groups, incidental VTE was associated with a higher risk of bleeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.